{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:03:24Z","timestamp":1780340604690,"version":"3.54.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inborn metabolic diseases (IMD) are rare conditions that can be diagnosed during adulthood. Patients with IMD may have joint symptoms and the challenge is to establish an early diagnosis in order to institute appropriate treatment and prevent irreversible damage. This review describes the joint manifestations of IMD that may be encountered in adults. The clinical settings considered were arthralgia and joint stiffness as well as arthritis. Unspecific arthralgias are often the first symptoms of hereditary hemochromatosis, chronic low back pain may reveal an intervertebral disc calcification in relation with alkaptonuria, and progressive joint stiffness may correspond to a mucopolysaccharidosis or mucolipidosis. Gaucher disease is initially revealed by painful acute attacks mimicking joint pain described as \u201cbone crises\u201d. Some IMD may induce microcrystalline arthropathy. Beyond classical gout, there are also gouts in connection with purine metabolism disorders known as \u201cenzymopathic gouts\u201d. Pyrophosphate arthropathy can also be part of the clinical spectrum of Gitelman syndrome or hypophosphatasia. Oxalate crystals arthritis can reveal a primary hyperoxaluria. Destructive arthritis may be indicative of Wilson\u2019s disease. Non-destructive arthritis may be seen in mevalonate kinase deficiency and familial hypercholesterolemia.<\/jats:p>","DOI":"10.1186\/s13023-023-02810-6","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T13:02:11Z","timestamp":1691672531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Joint manifestations revealing inborn metabolic diseases in adults: a narrative review"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4369-8424","authenticated-orcid":false,"given":"Amaury","family":"Loret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saloua","family":"Mammou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Audemard-Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida VD","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Mulleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"2810_CR1","doi-asserted-by":"publisher","unstructured":"Saudubray J-M, Sedel F. Inborn errors of metabolism in adults. Ann Endocrinol. 2009;70. https:\/\/doi.org\/10.1016\/j.ando.2008.12.004","DOI":"10.1016\/j.ando.2008.12.004"},{"key":"2810_CR2","doi-asserted-by":"publisher","unstructured":"Sirrs S, Hollak C, Merkel M, et al. The frequencies of different inborn errors of metabolism in adult metabolic Centres: Report from the SSIEM Adult Metabolic Physicians Group. JIMD Rep. 2015;27. https:\/\/doi.org\/10.1007\/8904_2015_435","DOI":"10.1007\/8904_2015_435"},{"key":"2810_CR3","doi-asserted-by":"publisher","unstructured":"Fouchard A-A, Corcia P, Allais C, et al. Inborn errors of metabolism in Elderly adults. J Am Geriatr Soc. 2016;64. https:\/\/doi.org\/10.1111\/jgs.14333","DOI":"10.1111\/jgs.14333"},{"key":"2810_CR4","doi-asserted-by":"publisher","unstructured":"Ranganath LR, Psarelli EE, Arnoux J-B, et al. Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2020;8. https:\/\/doi.org\/10.1016\/S2213-8587(20)30228-X","DOI":"10.1016\/S2213-8587(20)30228-X"},{"key":"2810_CR5","unstructured":"Brik R, Mandel H, Aizin A et al. Mucolipidosis III presenting as a rheumatological disorder. J Rheumatol 1993;20."},{"key":"2810_CR6","doi-asserted-by":"publisher","unstructured":"Finsterer J, Melichart-Kotig M, Woehrer A. Mitochondrial disorder mimicking rheumatoid disease. Z Rheumatol. 2019;78. https:\/\/doi.org\/10.1007\/s00393-018-0551-1","DOI":"10.1007\/s00393-018-0551-1"},{"key":"2810_CR7","doi-asserted-by":"publisher","unstructured":"Moiseev S, Karovaikina E, Novikov PI, et al. What rheumatologist should know about fabry disease. Ann Rheum Dis. 2020;79. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215476","DOI":"10.1136\/annrheumdis-2019-215476"},{"key":"2810_CR8","doi-asserted-by":"publisher","unstructured":"Brissot P, Pietrangelo A, Adams PC, et al. Haemochromatosis. Nat Rev Dis Primer. 2018;4. https:\/\/doi.org\/10.1038\/nrdp.2018.16","DOI":"10.1038\/nrdp.2018.16"},{"key":"2810_CR9","doi-asserted-by":"publisher","unstructured":"Contributors, Taskforce HI, Adams P, Altes A, et al. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y\/C282Y) homozygous genotype. Hepatol Int. 2018;12. https:\/\/doi.org\/10.1007\/s12072-018-9855-0","DOI":"10.1007\/s12072-018-9855-0"},{"key":"2810_CR10","doi-asserted-by":"crossref","unstructured":"Gasser B, Courtois F, Hojjat-Assari S et al. Hereditary hemochromatosis: presenting manifestations and diagnostic delay. Rev Med Interne 2014;35.","DOI":"10.1016\/j.revmed.2013.02.041"},{"key":"2810_CR11","doi-asserted-by":"publisher","unstructured":"Lange U, Teichmann J, Dischereit G. Molekulargenetische Analyse und klinische Aspekte bei Patienten mit heredit\u00e4rer H\u00e4mochromatose. Orthop. 2014;43. https:\/\/doi.org\/10.1007\/s00132-014-2318-y","DOI":"10.1007\/s00132-014-2318-y"},{"key":"2810_CR12","doi-asserted-by":"publisher","unstructured":"Schumacher HR, Straka PC, Krikker MA, et al. The Arthropathy of Hemochromatosis.: recent studies. Ann N Y Acad Sci. 1988;526. https:\/\/doi.org\/10.1111\/j.1749-6632.1988.tb55508.x","DOI":"10.1111\/j.1749-6632.1988.tb55508.x"},{"key":"2810_CR13","unstructured":"Romas E. The \u201ciron salute\u201d in haemochromatosis. Aust Fam Physician 2009;38."},{"key":"2810_CR14","doi-asserted-by":"publisher","unstructured":"Nguyen C-D, Morel V, Pierache A, et al. Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients. Ther Adv Musculoskelet Dis. 2020;12. https:\/\/doi.org\/10.1177\/1759720X20939405","DOI":"10.1177\/1759720X20939405"},{"key":"2810_CR15","doi-asserted-by":"crossref","unstructured":"Sahinbegovic E, Dallos T, Aigner E et al. Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum 2010;62.","DOI":"10.1002\/art.27712"},{"key":"2810_CR16","doi-asserted-by":"publisher","unstructured":"Wijarnpreecha K, Aby ES, Panjawatanan P, et al. Hereditary hemochromatosis and risk of joint replacement surgery: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2021;33. https:\/\/doi.org\/10.1097\/MEG.0000000000001704","DOI":"10.1097\/MEG.0000000000001704"},{"key":"2810_CR17","doi-asserted-by":"publisher","unstructured":"Carroll GJ, Breidahl WH, Bulsara MK, et al. Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum. 2011;63. https:\/\/doi.org\/10.1002\/art.30094","DOI":"10.1002\/art.30094"},{"key":"2810_CR18","unstructured":"Faridi W, Dhamoon AS. Ochronosis (Book), edited by StatPearls Publishing, 2022. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560534\/ (accessed Oct 2022)."},{"key":"2810_CR19","doi-asserted-by":"crossref","unstructured":"Ranganath LR, Cox TF. Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis 2011;34.","DOI":"10.1007\/s10545-011-9374-9"},{"key":"2810_CR20","doi-asserted-by":"crossref","unstructured":"Khan UN, Wenokor C, Altschuler EL. Back Pain in a middle-aged man: Alkaptonuria. Am J Phys Med Rehabil 2015;94.","DOI":"10.1097\/PHM.0000000000000253"},{"key":"2810_CR21","doi-asserted-by":"publisher","unstructured":"Khan AH, Afroze B, Majid H, et al. Musculoskeletal manifestations in Alkaptonuria: a cross-sectional study. Med (Baltim). 2021;100. https:\/\/doi.org\/10.1097\/MD.0000000000028241","DOI":"10.1097\/MD.0000000000028241"},{"key":"2810_CR22","doi-asserted-by":"crossref","unstructured":"Mannoni A, Selvi E, Lorenzini S et al. Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum 2004;33.","DOI":"10.1053\/S0049-0172(03)00080-5"},{"key":"2810_CR23","doi-asserted-by":"publisher","unstructured":"Ladjouze-Rezig A, Rodriguez de Cordoba S, Aquaron R. Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies\u2014a case study of 14 patients in 11 families. Joint Bone Spine. 2006;73. https:\/\/doi.org\/10.1016\/j.jbspin.2005.03.010","DOI":"10.1016\/j.jbspin.2005.03.010"},{"key":"2810_CR24","doi-asserted-by":"publisher","unstructured":"Cetinus E, Cever I, Kural C, et al. Ochronotic arthritis: case reports and review of the literature. Rheumatol Int. 2005;25. https:\/\/doi.org\/10.1007\/s00296-004-0538-x","DOI":"10.1007\/s00296-004-0538-x"},{"key":"2810_CR25","doi-asserted-by":"publisher","unstructured":"Demir S. Alkaptonuric ochronosis: a case with multiple joint replacement arthroplasties. Clin Rheumatol. 2003;22. https:\/\/doi.org\/10.1007\/s10067-003-0760-z","DOI":"10.1007\/s10067-003-0760-z"},{"key":"2810_CR26","doi-asserted-by":"publisher","unstructured":"Raaijmaakers M, Steenbrugge F, Dierickx C. Ochronosis, arthroscopy of a black knee: a case report and review of the literature. Knee Surg Sports Traumatol Arthrosc Off J ESSKA. 2008;16. https:\/\/doi.org\/10.1007\/s00167-007-0413-x","DOI":"10.1007\/s00167-007-0413-x"},{"key":"2810_CR27","doi-asserted-by":"publisher","unstructured":"de Haas V, Weber ECC, de Klerk JBC, et al. The success of dietary protein restriction in alkaptonuria patients is age-dependent. J Inherit Metab Dis. 1998;21. https:\/\/doi.org\/10.1023\/A:1005410416482","DOI":"10.1023\/A:1005410416482"},{"key":"2810_CR28","doi-asserted-by":"publisher","unstructured":"Rajkumar N, Soundarrajan D, Dhanasekararaja P, et al. Clinical and radiological outcomes of total joint arthroplasty in patients with ochronotic arthropathy. Eur J Orthop Surg Traumatol Orthop Traumatol. 2020;30. https:\/\/doi.org\/10.1007\/s00590-020-02651-0","DOI":"10.1007\/s00590-020-02651-0"},{"key":"2810_CR29","doi-asserted-by":"publisher","unstructured":"Khan SA, Peracha H, Ballhausen D, et al. Molecular Genetics and Metabolism. Mol Genet Metab. 2017;121. https:\/\/doi.org\/10.1016\/j.ymgme.2017.05.016","DOI":"10.1016\/j.ymgme.2017.05.016"},{"key":"2810_CR30","doi-asserted-by":"publisher","unstructured":"Mitrovic S, Gouze H, Gossec L, et al. Mucopolysaccharidoses seen in adults in rheumatology. Joint Bone Spine. 2017;84. https:\/\/doi.org\/10.1016\/j.jbspin.2017.01.008","DOI":"10.1016\/j.jbspin.2017.01.008"},{"key":"2810_CR31","doi-asserted-by":"crossref","unstructured":"Cimaz R, Coppa GV, Kon\u00e9-Paut I et al. Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J 2009;7.","DOI":"10.1186\/1546-0096-7-18"},{"key":"2810_CR32","unstructured":"Cimaz R, Vijay S, Haase C et al. Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome. Clin Exp Rheumatol 2006;24."},{"key":"2810_CR33","doi-asserted-by":"publisher","unstructured":"Williams N, Challoumas D, Eastwood DM. Does orthopaedic surgery improve quality of life and function in patients with mucopolysaccharidoses? J Child Orthop. 2017;11. https:\/\/doi.org\/10.1302\/1863-2548.11.170042","DOI":"10.1302\/1863-2548.11.170042"},{"key":"2810_CR34","doi-asserted-by":"crossref","unstructured":"Umehara F, Matsumoto W, Kuriyama M et al. Mucolipidosis III (pseudo-hurler polydystrophy); clinical studies in aged patients in one family. J Neurol Sci 1997;146.","DOI":"10.1016\/S0022-510X(96)00301-2"},{"key":"2810_CR35","doi-asserted-by":"publisher","unstructured":"Khalifa H, Grubisa HS, Lee L, et al. Enlarged follicles and temporomandibular joint abnormalities in mucolipidosis type III. Dento Maxillo Facial Radiol. 2013;42. https:\/\/doi.org\/10.1259\/dmfr\/22822014","DOI":"10.1259\/dmfr\/22822014"},{"key":"2810_CR36","doi-asserted-by":"publisher","unstructured":"Lewis JRP, Gibson PH. Bilateral hip replacement in three patients with lysosomal storage disease: mucopolysaccharidosis type IV and mucolipidosis type III. J Bone Joint Surg Br. 2010;92. https:\/\/doi.org\/10.1302\/0301-620X.92B2.23104","DOI":"10.1302\/0301-620X.92B2.23104"},{"key":"2810_CR37","doi-asserted-by":"publisher","unstructured":"Stirnemann J, Vigan M, Hamroun D, et al. The french Gaucher\u2019s disease registry: clinical characteristics, complications and treatment of 562 patients. Orphanet J Rare Dis. 2012;7. https:\/\/doi.org\/10.1186\/1750-1172-7-77","DOI":"10.1186\/1750-1172-7-77"},{"key":"2810_CR38","doi-asserted-by":"publisher","unstructured":"Javier R-M, Hachulla \u00c9. Atteintes ost\u00e9oarticulaires de la maladie de gaucher chez l\u2019adulte: de la physiopathologie au traitement. Presse M\u00e9dicale. 2007;36. https:\/\/doi.org\/10.1016\/j.lpm.2007.04.012","DOI":"10.1016\/j.lpm.2007.04.012"},{"key":"2810_CR39","doi-asserted-by":"publisher","unstructured":"Manger B, Mengel E, Schaefer RM. Rheumatologic aspects of lysosomal storage diseases. Clin Rheumatol. 2007;26. https:\/\/doi.org\/10.1007\/s10067-006-0299-x","DOI":"10.1007\/s10067-006-0299-x"},{"key":"2810_CR40","doi-asserted-by":"crossref","unstructured":"Weinreb NJ, Goldblatt J, Villalobos J et al. Long-term clinical outcomes in type 1 gaucher disease following 10 years of imiglucerase treatment. J Inherit Metab Dis 2013;36.","DOI":"10.1007\/s10545-012-9528-4"},{"key":"2810_CR41","doi-asserted-by":"crossref","unstructured":"Serratrice C, Bengherbia M, Alessandrini M et al. Effects of switching from imiglucerase to velaglucerase alfa without dose reduction nor wash out in type 1 gaucher disease. Blood Cells Mol Dis 2014;53.","DOI":"10.1016\/j.bcmd.2013.12.004"},{"key":"2810_CR42","doi-asserted-by":"crossref","unstructured":"Pastores GM, Petakov M, Giraldo P et al. A phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with gaucher disease previously treated with imiglucerase. Blood Cells Mol Dis 2014;53.","DOI":"10.1016\/j.bcmd.2014.05.004"},{"key":"2810_CR43","doi-asserted-by":"publisher","unstructured":"Cox TM, Drelichman G, Cravo R, et al. Eliglustat compared with imiglucerase in patients with Gaucher\u2019s disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. Lancet Lond Engl. 2015;385. https:\/\/doi.org\/10.1016\/S0140-6736(14)61841-9","DOI":"10.1016\/S0140-6736(14)61841-9"},{"key":"2810_CR44","doi-asserted-by":"publisher","unstructured":"Doucet BP, Jegatheesan D, Burke J. Late diagnosis of Lesch-Nyhan disease variant. BMJ Case Rep 2013;2013. doi:https:\/\/doi.org\/10.1136\/bcr-2013-201997","DOI":"10.1136\/bcr-2013-201997"},{"key":"2810_CR45","unstructured":"Saigal R, Chakraborty A, Yadav RN et al. Partial HPRT deficiency (Kelley-Seegmiller syndrome. J Assoc Physicians India 2006;54."},{"key":"2810_CR46","doi-asserted-by":"publisher","unstructured":"Madeo A, Di Rocco M, Brassier A, et al. Clinical, biochemical and genetic characteristics of a cohort of 101 french and italian patients with HPRT deficiency. Mol Genet Metab. 2019;127. https:\/\/doi.org\/10.1016\/j.ymgme.2019.06.001","DOI":"10.1016\/j.ymgme.2019.06.001"},{"key":"2810_CR47","doi-asserted-by":"publisher","unstructured":"Favero M, Cal\u00f2 LA, Schiavon F, et al. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter\u2019s and Gitelman\u2019s diseases. Best Pract Res Clin Rheumatol. 2011;25. https:\/\/doi.org\/10.1016\/j.berh.2011.10.013","DOI":"10.1016\/j.berh.2011.10.013"},{"key":"2810_CR48","doi-asserted-by":"publisher","unstructured":"Kim YK, Song HC, Kim W-Y, et al. Acquired Gitelman Syndrome in a patient with primary Sj\u00f6gren Syndrome. Am J Kidney Dis. 2008;52. https:\/\/doi.org\/10.1053\/j.ajkd.2008.07.025","DOI":"10.1053\/j.ajkd.2008.07.025"},{"key":"2810_CR49","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez Tom\u00e0s A, Rueda Cid A, Campos Fern\u00e1ndez C, et al. Carpal arthritis as the initial manifestation of Gitelman\u2019s syndrome. Reumatol Cl\u00ednica Engl Ed. 2012;8. https:\/\/doi.org\/10.1016\/j.reumae.2011.11.006","DOI":"10.1016\/j.reumae.2011.11.006"},{"key":"2810_CR50","doi-asserted-by":"publisher","unstructured":"Chotard E, Blanchard A, Ostertag A, et al. Calcium pyrophosphate crystal deposition in a cohort of 57 patients with Gitelman syndrome. Rheumatology. 2022;61. https:\/\/doi.org\/10.1093\/rheumatology\/keab578","DOI":"10.1093\/rheumatology\/keab578"},{"key":"2810_CR51","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8594","author":"A Bangura","year":"2020","unstructured":"Bangura A, Wright L, Shuler T. Hypophosphatasia: current literature for pathophysiology, clinical manifestations, diagnosis, and treatment. Cureus. 2020. https:\/\/doi.org\/10.7759\/cureus.8594","journal-title":"Cureus"},{"key":"2810_CR52","doi-asserted-by":"publisher","unstructured":"Dahir KM, Seefried L, Kishnani PS, et al. Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP Registry. Orphanet J Rare Dis. 2022;17. https:\/\/doi.org\/10.1186\/s13023-022-02393-8","DOI":"10.1186\/s13023-022-02393-8"},{"key":"2810_CR53","doi-asserted-by":"publisher","unstructured":"Szabo SM, Tomazos IC, Petryk A, et al. Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review. Orphanet J Rare Dis. 2019;14. https:\/\/doi.org\/10.1186\/s13023-019-1062-0","DOI":"10.1186\/s13023-019-1062-0"},{"key":"2810_CR54","doi-asserted-by":"publisher","unstructured":"Michigami T, Ohata Y, Fujiwara M, et al. Clinical practice guidelines for Hypophosphatasia. Clin Pediatr Endocrinol. 2020;29. https:\/\/doi.org\/10.1297\/cpe.29.9","DOI":"10.1297\/cpe.29.9"},{"key":"2810_CR55","doi-asserted-by":"publisher","unstructured":"Martin M et al. Delayed diagnosis of primary hyperoxaluria in a young patient with advanced chronic renal failure. Nefrolog\u00eda 2011. doi:https:\/\/doi.org\/10.3265\/Nefrologia.pre2010.Nov.10725","DOI":"10.3265\/Nefrologia.pre2010.Nov.10725"},{"key":"2810_CR56","unstructured":"Verbruggen LA, Bourgain C, Verbeelen D. Late presentation and microcrystalline arthropathy in primary hyperoxaluria. Clin Exp Rheumatol 1989;7."},{"key":"2810_CR57","doi-asserted-by":"publisher","unstructured":"Lorenz EC, Michet CJ, Milliner DS, et al. Update on Oxalate Crystal Disease. Curr Rheumatol Rep. 2013;15. https:\/\/doi.org\/10.1007\/s11926-013-0340-4","DOI":"10.1007\/s11926-013-0340-4"},{"key":"2810_CR58","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.05.012","author":"M Michael","year":"2022","unstructured":"Michael M, Groothoff JW, Shasha-Lavsky H, et al. Lumasiran for Advanced primary hyperoxaluria type 1: phase 3 ILLUMINATE-C trial. Am J Kidney Dis Off J Natl Kidney Found. 2022. https:\/\/doi.org\/10.1053\/j.ajkd.2022.05.012","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"2810_CR59","doi-asserted-by":"publisher","unstructured":"Cochat P, Hulton S-A, Acquaviva C, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012;27. https:\/\/doi.org\/10.1093\/ndt\/gfs078","DOI":"10.1093\/ndt\/gfs078"},{"key":"2810_CR60","doi-asserted-by":"publisher","unstructured":"Guindi M. Wilson disease. Semin Diagn Pathol. 2019;36. https:\/\/doi.org\/10.1053\/j.semdp.2019.07.008","DOI":"10.1053\/j.semdp.2019.07.008"},{"key":"2810_CR61","doi-asserted-by":"publisher","unstructured":"Salman HM, Amin M, Syed J, et al. Biochemical testing for the diagnosis of Wilson\u2019s disease: a systematic review. J Clin Lab Anal. 2022;36. https:\/\/doi.org\/10.1002\/jcla.24191","DOI":"10.1002\/jcla.24191"},{"key":"2810_CR62","doi-asserted-by":"publisher","unstructured":"Espin\u00f3s C, Ferenci P. Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice? JHEP Rep. 2020;2. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100114","DOI":"10.1016\/j.jhepr.2020.100114"},{"key":"2810_CR63","doi-asserted-by":"publisher","unstructured":"Zhu Q, Zhu K, Wang J, et al. Relationship between genetic mutations and clinical phenotypes in patients with Wilson disease. Med (Baltim). 2019;98. https:\/\/doi.org\/10.1097\/MD.0000000000018284","DOI":"10.1097\/MD.0000000000018284"},{"key":"2810_CR64","doi-asserted-by":"publisher","unstructured":"Wickrematilake GW. Calcium pyrophosphate Dihydrate Deposition Disease in Young Patients: two case reports. Arch Rheumatol. 2016;32. https:\/\/doi.org\/10.5606\/ArchRheumatol.2017.6015","DOI":"10.5606\/ArchRheumatol.2017.6015"},{"key":"2810_CR65","unstructured":"Misra AK, Biswas A, Ganguly G et al. Arthropathic presentation of Wilson\u2019s disease. J Assoc Physicians India 2004;52."},{"key":"2810_CR66","doi-asserted-by":"publisher","unstructured":"Appenzeller-Herzog C, Mathes T, Heeres MLS, et al. Comparative effectiveness of common therapies for Wilson disease: a systematic review and meta-analysis of controlled studies. Liver Int Off J Int Assoc Study Liver. 2019;39. https:\/\/doi.org\/10.1111\/liv.14179","DOI":"10.1111\/liv.14179"},{"key":"2810_CR67","doi-asserted-by":"publisher","unstructured":"ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The phenotype and genotype of mevalonate kinase Deficiency: a series of 114 cases from the Eurofever Registry. Arthritis Rheumatol. 2016;68. https:\/\/doi.org\/10.1002\/art.39763","DOI":"10.1002\/art.39763"},{"key":"2810_CR68","doi-asserted-by":"publisher","unstructured":"Georgin-Lavialle S, Ducharme-Benard S, Sarrabay G, et al. Systemic autoinflammatory diseases: clinical state of the art. Best Pract Res Clin Rheumatol. 2020;34. https:\/\/doi.org\/10.1016\/j.berh.2020.101529","DOI":"10.1016\/j.berh.2020.101529"},{"key":"2810_CR69","doi-asserted-by":"publisher","unstructured":"van der Hilst JCH, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Med (Baltim). 2008;87. https:\/\/doi.org\/10.1097\/MD.0b013e318190cfb7","DOI":"10.1097\/MD.0b013e318190cfb7"},{"key":"2810_CR70","doi-asserted-by":"publisher","unstructured":"Romano M, Arici ZS, Piskin D, et al. The 2021 EULAR\/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis. 2022;81. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221801","DOI":"10.1136\/annrheumdis-2021-221801"},{"key":"2810_CR71","doi-asserted-by":"publisher","unstructured":"Wadsack D, Sattler H, Kleber ME, et al. Recurrent tendosynovitis as a rare manifestation of a lipid disorder. J Clin Lipidol. 2019;13. https:\/\/doi.org\/10.1016\/j.jacl.2018.10.005","DOI":"10.1016\/j.jacl.2018.10.005"},{"key":"2810_CR72","unstructured":"Turgeon RD, Barry AR, Pearson GJ. Hypercholest\u00e9rol\u00e9mie familiale. Can Fam Physician 2016;62."},{"key":"2810_CR73","doi-asserted-by":"publisher","unstructured":"Tsouli SG, Kiortsis DN, Argyropoulou MI, et al. Pathogenesis, detection and treatment of Achilles tendon xanthomas. Eur J Clin Invest. 2005;35. https:\/\/doi.org\/10.1111\/j.1365-2362.2005.01484.x","DOI":"10.1111\/j.1365-2362.2005.01484.x"},{"key":"2810_CR74","unstructured":"Wysenbeek AJ, Shani E, Beigel Y. Musculoskeletal manifestations in patients with hypercholesterolemia. J Rheumatol 1989;16."},{"key":"2810_CR75","doi-asserted-by":"publisher","unstructured":"Tarpley AJ. New Frontier in lipids: PCSK9 inhibitors and implications for the Life Insurance Industry. J Insur Med N Y N. 2018;47. https:\/\/doi.org\/10.17849\/insm-47-4-1-6.1","DOI":"10.17849\/insm-47-4-1-6.1"},{"key":"2810_CR76","doi-asserted-by":"publisher","unstructured":"Fujiwara R, Yahiro R, Horio T, et al. Achilles tendon thickness is associated with coronary lesion severity in acute coronary syndrome patients without familial hypercholesterolemia. J Cardiol. 2022;79. https:\/\/doi.org\/10.1016\/j.jjcc.2021.09.021","DOI":"10.1016\/j.jjcc.2021.09.021"},{"key":"2810_CR77","doi-asserted-by":"publisher","unstructured":"Tada H, Nomura A, Ogura M, et al. Diagnosis and management of sitosterolemia 2021. J Atheroscler Thromb. 2021;28. https:\/\/doi.org\/10.5551\/jat.RV17052","DOI":"10.5551\/jat.RV17052"},{"key":"2810_CR78","doi-asserted-by":"publisher","unstructured":"Wang Z, Cao L, Su Y, et al. Specific macrothrombocytopenia\/hemolytic anemia associated with sitosterolemia. Am J Hematol. 2014;89. https:\/\/doi.org\/10.1002\/ajh.23619","DOI":"10.1002\/ajh.23619"},{"key":"2810_CR79","doi-asserted-by":"publisher","unstructured":"Cao LJ, Yu ZJ, Jiang M, et al. Clinical features of 20 patients with phytosterolemia causing hematologic abnormalities. Zhonghua Yi Xue Za Zhi. 2019;99. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2019.16.007","DOI":"10.3760\/cma.j.issn.0376-2491.2019.16.007"},{"key":"2810_CR80","doi-asserted-by":"publisher","unstructured":"Zhou Z, Su X, Cai Y, et al. Features of chinese patients with sitosterolemia. Lipids Health Dis. 2022;21. https:\/\/doi.org\/10.1186\/s12944-021-01619-1","DOI":"10.1186\/s12944-021-01619-1"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02810-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02810-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02810-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:14:45Z","timestamp":1700640885000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02810-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2810"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02810-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"26 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}